Sign up for a free 30 day trial, find out more
Connell C - LB Mar 2022

Medtech start-up PreciPoint raises €10m

Freising, Germany-based medtech start-up PreciPoint Group has closed a €10 million Series A funding round.

Existing investors around venture capital and private equity firm beteiligungsmanagement thüringen (bm|t) and a new family office are investing.

PreciPoint Group is using this financing to expand international commercialisation of its in vitro diagnostics medical product, market entry in the US, and further technological development.

PreciPoint produces solutions for the digitalisation of microscopy and laboratory processes for applications in medicine, research and education. The company stated it is launching a solution for the digitalisation of intraoperative assessments during cancer surgeries, which are traditionally bound to location and time using classic microscopes.

Stefan Jahn, senior investment manager at bm|t, said: “Since our seed investment in 2019, the team around the two co-founders and managing directors Nicolas Weiss and Dominik Gerber has made enormous progress. Renowned distribution partners could be acquired, new products could be developed and successfully placed on the market. At the same time, the prerequisites were created to quickly scale the company. We firmly believe that PreciPoint, as a ISO13485 certified medical device company, will be able to successfully position its product portfolio on the European and American markets.”

Subscriber content

To get unlimited access subscribe today

Subscribe

Already a subscriber? Login

Talk to our team

Zina Fragkiadaki 0207 451 7058 Editor

Caroline Bowern 0797 4643292 Advertising and sales manager